Pharma & Healthcare
Global Breviscapine for Injection Market Research Report 2025
- Apr 16, 25
- ID: 195546
- Pages: 86
- Figures: 83
- Views: 53
The global market for Breviscapine for Injection was valued at US$ 459 million in the year 2024 and is projected to reach a revised size of US$ 551 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Breviscapine for injection is a sterile injection made from the traditional Chinese medicine Breviscapine, which is extracted by modern technology to extract the active ingredients (mainly scutellarin), and has the effects of promoting blood circulation, removing blood stasis, unblocking meridians and relieving pain. Its main ingredient is scutellarin, which is clinically used to treat stroke sequelae, coronary heart disease, angina pectoris and other cardiovascular and cerebrovascular diseases.
North American market for Breviscapine for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Breviscapine for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Breviscapine for Injection include Kunming Longjin Pharmaceutical, China Shineway Pharmaceutical, YUNNAN BIOVALLEY PHARMACEUTICAL, Hunan Hengsheng Pharmaceutical, Tasly Pharmaceutical Group, KPC Pharmaceuticals, Sihuan Pharmaceutical, CSPC Pharmaceutical Group, Jilin Longtai Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Breviscapine for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breviscapine for Injection.
The Breviscapine for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Breviscapine for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breviscapine for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Kunming Longjin Pharmaceutical
China Shineway Pharmaceutical
YUNNAN BIOVALLEY PHARMACEUTICAL
Hunan Hengsheng Pharmaceutical
Tasly Pharmaceutical Group
KPC Pharmaceuticals
Sihuan Pharmaceutical
CSPC Pharmaceutical Group
Jilin Longtai Pharmaceutical
Segment by Type
Freeze-Dried Powder
Aqueous Solution
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Breviscapine for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Breviscapine for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Breviscapine for injection is a sterile injection made from the traditional Chinese medicine Breviscapine, which is extracted by modern technology to extract the active ingredients (mainly scutellarin), and has the effects of promoting blood circulation, removing blood stasis, unblocking meridians and relieving pain. Its main ingredient is scutellarin, which is clinically used to treat stroke sequelae, coronary heart disease, angina pectoris and other cardiovascular and cerebrovascular diseases.
North American market for Breviscapine for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Breviscapine for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Breviscapine for Injection include Kunming Longjin Pharmaceutical, China Shineway Pharmaceutical, YUNNAN BIOVALLEY PHARMACEUTICAL, Hunan Hengsheng Pharmaceutical, Tasly Pharmaceutical Group, KPC Pharmaceuticals, Sihuan Pharmaceutical, CSPC Pharmaceutical Group, Jilin Longtai Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Breviscapine for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breviscapine for Injection.
The Breviscapine for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Breviscapine for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breviscapine for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Kunming Longjin Pharmaceutical
China Shineway Pharmaceutical
YUNNAN BIOVALLEY PHARMACEUTICAL
Hunan Hengsheng Pharmaceutical
Tasly Pharmaceutical Group
KPC Pharmaceuticals
Sihuan Pharmaceutical
CSPC Pharmaceutical Group
Jilin Longtai Pharmaceutical
Segment by Type
Freeze-Dried Powder
Aqueous Solution
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Breviscapine for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Breviscapine for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Breviscapine for Injection Market Overview
1.1 Product Definition
1.2 Breviscapine for Injection by Type
1.2.1 Global Breviscapine for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Freeze-Dried Powder
1.2.3 Aqueous Solution
1.3 Breviscapine for Injection by Application
1.3.1 Global Breviscapine for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Breviscapine for Injection Market Size Estimates and Forecasts
1.4.1 Global Breviscapine for Injection Revenue 2020-2031
1.4.2 Global Breviscapine for Injection Sales 2020-2031
1.4.3 Global Breviscapine for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Breviscapine for Injection Market Competition by Manufacturers
2.1 Global Breviscapine for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Breviscapine for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Breviscapine for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Breviscapine for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Breviscapine for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Breviscapine for Injection, Product Type & Application
2.7 Global Key Manufacturers of Breviscapine for Injection, Date of Enter into This Industry
2.8 Global Breviscapine for Injection Market Competitive Situation and Trends
2.8.1 Global Breviscapine for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Breviscapine for Injection Players Market Share by Revenue
2.8.3 Global Breviscapine for Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Breviscapine for Injection Market Scenario by Region
3.1 Global Breviscapine for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Breviscapine for Injection Sales by Region: 2020-2031
3.2.1 Global Breviscapine for Injection Sales by Region: 2020-2025
3.2.2 Global Breviscapine for Injection Sales by Region: 2026-2031
3.3 Global Breviscapine for Injection Revenue by Region: 2020-2031
3.3.1 Global Breviscapine for Injection Revenue by Region: 2020-2025
3.3.2 Global Breviscapine for Injection Revenue by Region: 2026-2031
3.4 North America Breviscapine for Injection Market Facts & Figures by Country
3.4.1 North America Breviscapine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Breviscapine for Injection Sales by Country (2020-2031)
3.4.3 North America Breviscapine for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Breviscapine for Injection Market Facts & Figures by Country
3.5.1 Europe Breviscapine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Breviscapine for Injection Sales by Country (2020-2031)
3.5.3 Europe Breviscapine for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Breviscapine for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Breviscapine for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Breviscapine for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Breviscapine for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Breviscapine for Injection Market Facts & Figures by Country
3.7.1 Latin America Breviscapine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Breviscapine for Injection Sales by Country (2020-2031)
3.7.3 Latin America Breviscapine for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Breviscapine for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Breviscapine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Breviscapine for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Breviscapine for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Breviscapine for Injection Sales by Type (2020-2031)
4.1.1 Global Breviscapine for Injection Sales by Type (2020-2025)
4.1.2 Global Breviscapine for Injection Sales by Type (2026-2031)
4.1.3 Global Breviscapine for Injection Sales Market Share by Type (2020-2031)
4.2 Global Breviscapine for Injection Revenue by Type (2020-2031)
4.2.1 Global Breviscapine for Injection Revenue by Type (2020-2025)
4.2.2 Global Breviscapine for Injection Revenue by Type (2026-2031)
4.2.3 Global Breviscapine for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Breviscapine for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Breviscapine for Injection Sales by Application (2020-2031)
5.1.1 Global Breviscapine for Injection Sales by Application (2020-2025)
5.1.2 Global Breviscapine for Injection Sales by Application (2026-2031)
5.1.3 Global Breviscapine for Injection Sales Market Share by Application (2020-2031)
5.2 Global Breviscapine for Injection Revenue by Application (2020-2031)
5.2.1 Global Breviscapine for Injection Revenue by Application (2020-2025)
5.2.2 Global Breviscapine for Injection Revenue by Application (2026-2031)
5.2.3 Global Breviscapine for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Breviscapine for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Kunming Longjin Pharmaceutical
6.1.1 Kunming Longjin Pharmaceutical Company Information
6.1.2 Kunming Longjin Pharmaceutical Description and Business Overview
6.1.3 Kunming Longjin Pharmaceutical Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Kunming Longjin Pharmaceutical Breviscapine for Injection Product Portfolio
6.1.5 Kunming Longjin Pharmaceutical Recent Developments/Updates
6.2 China Shineway Pharmaceutical
6.2.1 China Shineway Pharmaceutical Company Information
6.2.2 China Shineway Pharmaceutical Description and Business Overview
6.2.3 China Shineway Pharmaceutical Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 China Shineway Pharmaceutical Breviscapine for Injection Product Portfolio
6.2.5 China Shineway Pharmaceutical Recent Developments/Updates
6.3 YUNNAN BIOVALLEY PHARMACEUTICAL
6.3.1 YUNNAN BIOVALLEY PHARMACEUTICAL Company Information
6.3.2 YUNNAN BIOVALLEY PHARMACEUTICAL Description and Business Overview
6.3.3 YUNNAN BIOVALLEY PHARMACEUTICAL Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 YUNNAN BIOVALLEY PHARMACEUTICAL Breviscapine for Injection Product Portfolio
6.3.5 YUNNAN BIOVALLEY PHARMACEUTICAL Recent Developments/Updates
6.4 Hunan Hengsheng Pharmaceutical
6.4.1 Hunan Hengsheng Pharmaceutical Company Information
6.4.2 Hunan Hengsheng Pharmaceutical Description and Business Overview
6.4.3 Hunan Hengsheng Pharmaceutical Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hunan Hengsheng Pharmaceutical Breviscapine for Injection Product Portfolio
6.4.5 Hunan Hengsheng Pharmaceutical Recent Developments/Updates
6.5 Tasly Pharmaceutical Group
6.5.1 Tasly Pharmaceutical Group Company Information
6.5.2 Tasly Pharmaceutical Group Description and Business Overview
6.5.3 Tasly Pharmaceutical Group Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tasly Pharmaceutical Group Breviscapine for Injection Product Portfolio
6.5.5 Tasly Pharmaceutical Group Recent Developments/Updates
6.6 KPC Pharmaceuticals
6.6.1 KPC Pharmaceuticals Company Information
6.6.2 KPC Pharmaceuticals Description and Business Overview
6.6.3 KPC Pharmaceuticals Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 KPC Pharmaceuticals Breviscapine for Injection Product Portfolio
6.6.5 KPC Pharmaceuticals Recent Developments/Updates
6.7 Sihuan Pharmaceutical
6.7.1 Sihuan Pharmaceutical Company Information
6.7.2 Sihuan Pharmaceutical Description and Business Overview
6.7.3 Sihuan Pharmaceutical Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sihuan Pharmaceutical Breviscapine for Injection Product Portfolio
6.7.5 Sihuan Pharmaceutical Recent Developments/Updates
6.8 CSPC Pharmaceutical Group
6.8.1 CSPC Pharmaceutical Group Company Information
6.8.2 CSPC Pharmaceutical Group Description and Business Overview
6.8.3 CSPC Pharmaceutical Group Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CSPC Pharmaceutical Group Breviscapine for Injection Product Portfolio
6.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.9 Jilin Longtai Pharmaceutical
6.9.1 Jilin Longtai Pharmaceutical Company Information
6.9.2 Jilin Longtai Pharmaceutical Description and Business Overview
6.9.3 Jilin Longtai Pharmaceutical Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jilin Longtai Pharmaceutical Breviscapine for Injection Product Portfolio
6.9.5 Jilin Longtai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Breviscapine for Injection Industry Chain Analysis
7.2 Breviscapine for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Breviscapine for Injection Production Mode & Process Analysis
7.4 Breviscapine for Injection Sales and Marketing
7.4.1 Breviscapine for Injection Sales Channels
7.4.2 Breviscapine for Injection Distributors
7.5 Breviscapine for Injection Customer Analysis
8 Breviscapine for Injection Market Dynamics
8.1 Breviscapine for Injection Industry Trends
8.2 Breviscapine for Injection Market Drivers
8.3 Breviscapine for Injection Market Challenges
8.4 Breviscapine for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Breviscapine for Injection by Type
1.2.1 Global Breviscapine for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Freeze-Dried Powder
1.2.3 Aqueous Solution
1.3 Breviscapine for Injection by Application
1.3.1 Global Breviscapine for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Breviscapine for Injection Market Size Estimates and Forecasts
1.4.1 Global Breviscapine for Injection Revenue 2020-2031
1.4.2 Global Breviscapine for Injection Sales 2020-2031
1.4.3 Global Breviscapine for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Breviscapine for Injection Market Competition by Manufacturers
2.1 Global Breviscapine for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Breviscapine for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Breviscapine for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Breviscapine for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Breviscapine for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Breviscapine for Injection, Product Type & Application
2.7 Global Key Manufacturers of Breviscapine for Injection, Date of Enter into This Industry
2.8 Global Breviscapine for Injection Market Competitive Situation and Trends
2.8.1 Global Breviscapine for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Breviscapine for Injection Players Market Share by Revenue
2.8.3 Global Breviscapine for Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Breviscapine for Injection Market Scenario by Region
3.1 Global Breviscapine for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Breviscapine for Injection Sales by Region: 2020-2031
3.2.1 Global Breviscapine for Injection Sales by Region: 2020-2025
3.2.2 Global Breviscapine for Injection Sales by Region: 2026-2031
3.3 Global Breviscapine for Injection Revenue by Region: 2020-2031
3.3.1 Global Breviscapine for Injection Revenue by Region: 2020-2025
3.3.2 Global Breviscapine for Injection Revenue by Region: 2026-2031
3.4 North America Breviscapine for Injection Market Facts & Figures by Country
3.4.1 North America Breviscapine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Breviscapine for Injection Sales by Country (2020-2031)
3.4.3 North America Breviscapine for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Breviscapine for Injection Market Facts & Figures by Country
3.5.1 Europe Breviscapine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Breviscapine for Injection Sales by Country (2020-2031)
3.5.3 Europe Breviscapine for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Breviscapine for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Breviscapine for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Breviscapine for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Breviscapine for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Breviscapine for Injection Market Facts & Figures by Country
3.7.1 Latin America Breviscapine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Breviscapine for Injection Sales by Country (2020-2031)
3.7.3 Latin America Breviscapine for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Breviscapine for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Breviscapine for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Breviscapine for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Breviscapine for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Breviscapine for Injection Sales by Type (2020-2031)
4.1.1 Global Breviscapine for Injection Sales by Type (2020-2025)
4.1.2 Global Breviscapine for Injection Sales by Type (2026-2031)
4.1.3 Global Breviscapine for Injection Sales Market Share by Type (2020-2031)
4.2 Global Breviscapine for Injection Revenue by Type (2020-2031)
4.2.1 Global Breviscapine for Injection Revenue by Type (2020-2025)
4.2.2 Global Breviscapine for Injection Revenue by Type (2026-2031)
4.2.3 Global Breviscapine for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Breviscapine for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Breviscapine for Injection Sales by Application (2020-2031)
5.1.1 Global Breviscapine for Injection Sales by Application (2020-2025)
5.1.2 Global Breviscapine for Injection Sales by Application (2026-2031)
5.1.3 Global Breviscapine for Injection Sales Market Share by Application (2020-2031)
5.2 Global Breviscapine for Injection Revenue by Application (2020-2031)
5.2.1 Global Breviscapine for Injection Revenue by Application (2020-2025)
5.2.2 Global Breviscapine for Injection Revenue by Application (2026-2031)
5.2.3 Global Breviscapine for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Breviscapine for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Kunming Longjin Pharmaceutical
6.1.1 Kunming Longjin Pharmaceutical Company Information
6.1.2 Kunming Longjin Pharmaceutical Description and Business Overview
6.1.3 Kunming Longjin Pharmaceutical Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Kunming Longjin Pharmaceutical Breviscapine for Injection Product Portfolio
6.1.5 Kunming Longjin Pharmaceutical Recent Developments/Updates
6.2 China Shineway Pharmaceutical
6.2.1 China Shineway Pharmaceutical Company Information
6.2.2 China Shineway Pharmaceutical Description and Business Overview
6.2.3 China Shineway Pharmaceutical Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 China Shineway Pharmaceutical Breviscapine for Injection Product Portfolio
6.2.5 China Shineway Pharmaceutical Recent Developments/Updates
6.3 YUNNAN BIOVALLEY PHARMACEUTICAL
6.3.1 YUNNAN BIOVALLEY PHARMACEUTICAL Company Information
6.3.2 YUNNAN BIOVALLEY PHARMACEUTICAL Description and Business Overview
6.3.3 YUNNAN BIOVALLEY PHARMACEUTICAL Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 YUNNAN BIOVALLEY PHARMACEUTICAL Breviscapine for Injection Product Portfolio
6.3.5 YUNNAN BIOVALLEY PHARMACEUTICAL Recent Developments/Updates
6.4 Hunan Hengsheng Pharmaceutical
6.4.1 Hunan Hengsheng Pharmaceutical Company Information
6.4.2 Hunan Hengsheng Pharmaceutical Description and Business Overview
6.4.3 Hunan Hengsheng Pharmaceutical Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hunan Hengsheng Pharmaceutical Breviscapine for Injection Product Portfolio
6.4.5 Hunan Hengsheng Pharmaceutical Recent Developments/Updates
6.5 Tasly Pharmaceutical Group
6.5.1 Tasly Pharmaceutical Group Company Information
6.5.2 Tasly Pharmaceutical Group Description and Business Overview
6.5.3 Tasly Pharmaceutical Group Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tasly Pharmaceutical Group Breviscapine for Injection Product Portfolio
6.5.5 Tasly Pharmaceutical Group Recent Developments/Updates
6.6 KPC Pharmaceuticals
6.6.1 KPC Pharmaceuticals Company Information
6.6.2 KPC Pharmaceuticals Description and Business Overview
6.6.3 KPC Pharmaceuticals Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 KPC Pharmaceuticals Breviscapine for Injection Product Portfolio
6.6.5 KPC Pharmaceuticals Recent Developments/Updates
6.7 Sihuan Pharmaceutical
6.7.1 Sihuan Pharmaceutical Company Information
6.7.2 Sihuan Pharmaceutical Description and Business Overview
6.7.3 Sihuan Pharmaceutical Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sihuan Pharmaceutical Breviscapine for Injection Product Portfolio
6.7.5 Sihuan Pharmaceutical Recent Developments/Updates
6.8 CSPC Pharmaceutical Group
6.8.1 CSPC Pharmaceutical Group Company Information
6.8.2 CSPC Pharmaceutical Group Description and Business Overview
6.8.3 CSPC Pharmaceutical Group Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CSPC Pharmaceutical Group Breviscapine for Injection Product Portfolio
6.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.9 Jilin Longtai Pharmaceutical
6.9.1 Jilin Longtai Pharmaceutical Company Information
6.9.2 Jilin Longtai Pharmaceutical Description and Business Overview
6.9.3 Jilin Longtai Pharmaceutical Breviscapine for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jilin Longtai Pharmaceutical Breviscapine for Injection Product Portfolio
6.9.5 Jilin Longtai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Breviscapine for Injection Industry Chain Analysis
7.2 Breviscapine for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Breviscapine for Injection Production Mode & Process Analysis
7.4 Breviscapine for Injection Sales and Marketing
7.4.1 Breviscapine for Injection Sales Channels
7.4.2 Breviscapine for Injection Distributors
7.5 Breviscapine for Injection Customer Analysis
8 Breviscapine for Injection Market Dynamics
8.1 Breviscapine for Injection Industry Trends
8.2 Breviscapine for Injection Market Drivers
8.3 Breviscapine for Injection Market Challenges
8.4 Breviscapine for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Breviscapine for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Breviscapine for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Breviscapine for Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Breviscapine for Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Breviscapine for Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Breviscapine for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Breviscapine for Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Breviscapine for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Breviscapine for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Breviscapine for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Breviscapine for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Breviscapine for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Breviscapine for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breviscapine for Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Breviscapine for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Breviscapine for Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Breviscapine for Injection Sales Market Share by Region (2020-2025)
Table 19. Global Breviscapine for Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Breviscapine for Injection Sales Market Share by Region (2026-2031)
Table 21. Global Breviscapine for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Breviscapine for Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Breviscapine for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Breviscapine for Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Breviscapine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Breviscapine for Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Breviscapine for Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Breviscapine for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Breviscapine for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Breviscapine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Breviscapine for Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Breviscapine for Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Breviscapine for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Breviscapine for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Breviscapine for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Breviscapine for Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Breviscapine for Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Breviscapine for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Breviscapine for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Breviscapine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Breviscapine for Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Breviscapine for Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Breviscapine for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Breviscapine for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Breviscapine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Breviscapine for Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Breviscapine for Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Breviscapine for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Breviscapine for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Breviscapine for Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Breviscapine for Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Breviscapine for Injection Sales Market Share by Type (2020-2025)
Table 53. Global Breviscapine for Injection Sales Market Share by Type (2026-2031)
Table 54. Global Breviscapine for Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Breviscapine for Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Breviscapine for Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Breviscapine for Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Breviscapine for Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Breviscapine for Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Breviscapine for Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Breviscapine for Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Breviscapine for Injection Sales Market Share by Application (2020-2025)
Table 63. Global Breviscapine for Injection Sales Market Share by Application (2026-2031)
Table 64. Global Breviscapine for Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Breviscapine for Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Breviscapine for Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Breviscapine for Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Breviscapine for Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Breviscapine for Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Kunming Longjin Pharmaceutical Company Information
Table 71. Kunming Longjin Pharmaceutical Description and Business Overview
Table 72. Kunming Longjin Pharmaceutical Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Kunming Longjin Pharmaceutical Breviscapine for Injection Product
Table 74. Kunming Longjin Pharmaceutical Recent Developments/Updates
Table 75. China Shineway Pharmaceutical Company Information
Table 76. China Shineway Pharmaceutical Description and Business Overview
Table 77. China Shineway Pharmaceutical Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. China Shineway Pharmaceutical Breviscapine for Injection Product
Table 79. China Shineway Pharmaceutical Recent Developments/Updates
Table 80. YUNNAN BIOVALLEY PHARMACEUTICAL Company Information
Table 81. YUNNAN BIOVALLEY PHARMACEUTICAL Description and Business Overview
Table 82. YUNNAN BIOVALLEY PHARMACEUTICAL Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. YUNNAN BIOVALLEY PHARMACEUTICAL Breviscapine for Injection Product
Table 84. YUNNAN BIOVALLEY PHARMACEUTICAL Recent Developments/Updates
Table 85. Hunan Hengsheng Pharmaceutical Company Information
Table 86. Hunan Hengsheng Pharmaceutical Description and Business Overview
Table 87. Hunan Hengsheng Pharmaceutical Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Hunan Hengsheng Pharmaceutical Breviscapine for Injection Product
Table 89. Hunan Hengsheng Pharmaceutical Recent Developments/Updates
Table 90. Tasly Pharmaceutical Group Company Information
Table 91. Tasly Pharmaceutical Group Description and Business Overview
Table 92. Tasly Pharmaceutical Group Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Tasly Pharmaceutical Group Breviscapine for Injection Product
Table 94. Tasly Pharmaceutical Group Recent Developments/Updates
Table 95. KPC Pharmaceuticals Company Information
Table 96. KPC Pharmaceuticals Description and Business Overview
Table 97. KPC Pharmaceuticals Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. KPC Pharmaceuticals Breviscapine for Injection Product
Table 99. KPC Pharmaceuticals Recent Developments/Updates
Table 100. Sihuan Pharmaceutical Company Information
Table 101. Sihuan Pharmaceutical Description and Business Overview
Table 102. Sihuan Pharmaceutical Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sihuan Pharmaceutical Breviscapine for Injection Product
Table 104. Sihuan Pharmaceutical Recent Developments/Updates
Table 105. CSPC Pharmaceutical Group Company Information
Table 106. CSPC Pharmaceutical Group Description and Business Overview
Table 107. CSPC Pharmaceutical Group Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. CSPC Pharmaceutical Group Breviscapine for Injection Product
Table 109. CSPC Pharmaceutical Group Recent Developments/Updates
Table 110. Jilin Longtai Pharmaceutical Company Information
Table 111. Jilin Longtai Pharmaceutical Description and Business Overview
Table 112. Jilin Longtai Pharmaceutical Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Jilin Longtai Pharmaceutical Breviscapine for Injection Product
Table 114. Jilin Longtai Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Breviscapine for Injection Distributors List
Table 118. Breviscapine for Injection Customers List
Table 119. Breviscapine for Injection Market Trends
Table 120. Breviscapine for Injection Market Drivers
Table 121. Breviscapine for Injection Market Challenges
Table 122. Breviscapine for Injection Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Breviscapine for Injection
Figure 2. Global Breviscapine for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Breviscapine for Injection Market Share by Type: 2024 & 2031
Figure 4. Freeze-Dried Powder Product Picture
Figure 5. Aqueous Solution Product Picture
Figure 6. Global Breviscapine for Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Breviscapine for Injection Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Breviscapine for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Breviscapine for Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Breviscapine for Injection Sales (2020-2031) & (K Units)
Figure 14. Global Breviscapine for Injection Average Price (US$/Unit) & (2020-2031)
Figure 15. Breviscapine for Injection Report Years Considered
Figure 16. Breviscapine for Injection Sales Share by Manufacturers in 2024
Figure 17. Global Breviscapine for Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Breviscapine for Injection Players: Market Share by Revenue in Breviscapine for Injection in 2024
Figure 19. Breviscapine for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Breviscapine for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Breviscapine for Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Breviscapine for Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Breviscapine for Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Breviscapine for Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Breviscapine for Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Breviscapine for Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Breviscapine for Injection Sales Market Share by Country (2020-2031)
Figure 42. Latin America Breviscapine for Injection Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Breviscapine for Injection Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Breviscapine for Injection Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Breviscapine for Injection by Type (2020-2031)
Figure 53. Global Revenue Market Share of Breviscapine for Injection by Type (2020-2031)
Figure 54. Global Breviscapine for Injection Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Breviscapine for Injection by Application (2020-2031)
Figure 56. Global Revenue Market Share of Breviscapine for Injection by Application (2020-2031)
Figure 57. Global Breviscapine for Injection Price (US$/Unit) by Application (2020-2031)
Figure 58. Breviscapine for Injection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Breviscapine for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Breviscapine for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Breviscapine for Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Breviscapine for Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Breviscapine for Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Breviscapine for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Breviscapine for Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Breviscapine for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Breviscapine for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Breviscapine for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Breviscapine for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Breviscapine for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Breviscapine for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breviscapine for Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Breviscapine for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Breviscapine for Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Breviscapine for Injection Sales Market Share by Region (2020-2025)
Table 19. Global Breviscapine for Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Breviscapine for Injection Sales Market Share by Region (2026-2031)
Table 21. Global Breviscapine for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Breviscapine for Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Breviscapine for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Breviscapine for Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Breviscapine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Breviscapine for Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Breviscapine for Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Breviscapine for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Breviscapine for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Breviscapine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Breviscapine for Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Breviscapine for Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Breviscapine for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Breviscapine for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Breviscapine for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Breviscapine for Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Breviscapine for Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Breviscapine for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Breviscapine for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Breviscapine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Breviscapine for Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Breviscapine for Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Breviscapine for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Breviscapine for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Breviscapine for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Breviscapine for Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Breviscapine for Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Breviscapine for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Breviscapine for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Breviscapine for Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Breviscapine for Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Breviscapine for Injection Sales Market Share by Type (2020-2025)
Table 53. Global Breviscapine for Injection Sales Market Share by Type (2026-2031)
Table 54. Global Breviscapine for Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Breviscapine for Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Breviscapine for Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Breviscapine for Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Breviscapine for Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Breviscapine for Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Breviscapine for Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Breviscapine for Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Breviscapine for Injection Sales Market Share by Application (2020-2025)
Table 63. Global Breviscapine for Injection Sales Market Share by Application (2026-2031)
Table 64. Global Breviscapine for Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Breviscapine for Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Breviscapine for Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Breviscapine for Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Breviscapine for Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Breviscapine for Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Kunming Longjin Pharmaceutical Company Information
Table 71. Kunming Longjin Pharmaceutical Description and Business Overview
Table 72. Kunming Longjin Pharmaceutical Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Kunming Longjin Pharmaceutical Breviscapine for Injection Product
Table 74. Kunming Longjin Pharmaceutical Recent Developments/Updates
Table 75. China Shineway Pharmaceutical Company Information
Table 76. China Shineway Pharmaceutical Description and Business Overview
Table 77. China Shineway Pharmaceutical Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. China Shineway Pharmaceutical Breviscapine for Injection Product
Table 79. China Shineway Pharmaceutical Recent Developments/Updates
Table 80. YUNNAN BIOVALLEY PHARMACEUTICAL Company Information
Table 81. YUNNAN BIOVALLEY PHARMACEUTICAL Description and Business Overview
Table 82. YUNNAN BIOVALLEY PHARMACEUTICAL Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. YUNNAN BIOVALLEY PHARMACEUTICAL Breviscapine for Injection Product
Table 84. YUNNAN BIOVALLEY PHARMACEUTICAL Recent Developments/Updates
Table 85. Hunan Hengsheng Pharmaceutical Company Information
Table 86. Hunan Hengsheng Pharmaceutical Description and Business Overview
Table 87. Hunan Hengsheng Pharmaceutical Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Hunan Hengsheng Pharmaceutical Breviscapine for Injection Product
Table 89. Hunan Hengsheng Pharmaceutical Recent Developments/Updates
Table 90. Tasly Pharmaceutical Group Company Information
Table 91. Tasly Pharmaceutical Group Description and Business Overview
Table 92. Tasly Pharmaceutical Group Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Tasly Pharmaceutical Group Breviscapine for Injection Product
Table 94. Tasly Pharmaceutical Group Recent Developments/Updates
Table 95. KPC Pharmaceuticals Company Information
Table 96. KPC Pharmaceuticals Description and Business Overview
Table 97. KPC Pharmaceuticals Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. KPC Pharmaceuticals Breviscapine for Injection Product
Table 99. KPC Pharmaceuticals Recent Developments/Updates
Table 100. Sihuan Pharmaceutical Company Information
Table 101. Sihuan Pharmaceutical Description and Business Overview
Table 102. Sihuan Pharmaceutical Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sihuan Pharmaceutical Breviscapine for Injection Product
Table 104. Sihuan Pharmaceutical Recent Developments/Updates
Table 105. CSPC Pharmaceutical Group Company Information
Table 106. CSPC Pharmaceutical Group Description and Business Overview
Table 107. CSPC Pharmaceutical Group Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. CSPC Pharmaceutical Group Breviscapine for Injection Product
Table 109. CSPC Pharmaceutical Group Recent Developments/Updates
Table 110. Jilin Longtai Pharmaceutical Company Information
Table 111. Jilin Longtai Pharmaceutical Description and Business Overview
Table 112. Jilin Longtai Pharmaceutical Breviscapine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Jilin Longtai Pharmaceutical Breviscapine for Injection Product
Table 114. Jilin Longtai Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Breviscapine for Injection Distributors List
Table 118. Breviscapine for Injection Customers List
Table 119. Breviscapine for Injection Market Trends
Table 120. Breviscapine for Injection Market Drivers
Table 121. Breviscapine for Injection Market Challenges
Table 122. Breviscapine for Injection Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Breviscapine for Injection
Figure 2. Global Breviscapine for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Breviscapine for Injection Market Share by Type: 2024 & 2031
Figure 4. Freeze-Dried Powder Product Picture
Figure 5. Aqueous Solution Product Picture
Figure 6. Global Breviscapine for Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Breviscapine for Injection Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Breviscapine for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Breviscapine for Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Breviscapine for Injection Sales (2020-2031) & (K Units)
Figure 14. Global Breviscapine for Injection Average Price (US$/Unit) & (2020-2031)
Figure 15. Breviscapine for Injection Report Years Considered
Figure 16. Breviscapine for Injection Sales Share by Manufacturers in 2024
Figure 17. Global Breviscapine for Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Breviscapine for Injection Players: Market Share by Revenue in Breviscapine for Injection in 2024
Figure 19. Breviscapine for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Breviscapine for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Breviscapine for Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Breviscapine for Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Breviscapine for Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Breviscapine for Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Breviscapine for Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Breviscapine for Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Breviscapine for Injection Sales Market Share by Country (2020-2031)
Figure 42. Latin America Breviscapine for Injection Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Breviscapine for Injection Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Breviscapine for Injection Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Breviscapine for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Breviscapine for Injection by Type (2020-2031)
Figure 53. Global Revenue Market Share of Breviscapine for Injection by Type (2020-2031)
Figure 54. Global Breviscapine for Injection Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Breviscapine for Injection by Application (2020-2031)
Figure 56. Global Revenue Market Share of Breviscapine for Injection by Application (2020-2031)
Figure 57. Global Breviscapine for Injection Price (US$/Unit) by Application (2020-2031)
Figure 58. Breviscapine for Injection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232